Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Oncogenic drivers in 11q13 associated with prognosis in advanced oropharyngeal carcinomas (Expression data set)

ABSTRACT: Expression microarray analyses was used to analyze 33 OSCC to unveil potential prognostic markers. A quality control filter was applied based on Feature Extraction flags (NA replacing values). Cy3/Cy5 ratios were log2 transformed

ORGANISM(S): Homo sapiens

PROVIDER: GSE111390 | GEO | 2019/03/03

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Oncogenic drivers in 11q13 associated with prognosis in advanced oropharyngeal carcinomas (aCGH data set)

Project description:aCGH was used to evaluate 33 OSCC aiming to unveil potential prognostic markers.

2019-03-03 | GSE111393 | GEO

Oncogenic drivers in 11q13 associated with prognosis in advanced oropharyngeal carcinomas

Project description:This SuperSeries is composed of the SubSeries listed below.

2019-03-03 | GSE111395 | GEO

Integrated miRNA and mRNA expression analysis uncovers drug targets in squamous cell carcinoma patients [miRNA]

Project description:Expression microarray analyses was used to analyze 35 LSCC with reference sample of 5 normal tissue. A quality control filter was applied based on Feature Extraction flags (empty spaces replacing values)

2019-07-31 | GSE124678 | GEO

Integrated miRNA and mRNA expression analysis uncovers drug targets in squamous cell carcinoma patients [mRNA]

Project description:Expression microarray analyses was used to analyze 35 laryngeal squamous cell carcinoma (LSCC) with reference sample (pool of 5 normal tissue ). A quality control filter was applied based on Feature Extraction flags (empty spaces replacing values)

2019-07-31 | GSE123986 | GEO

Expression profiling identifies deregulated pathways and top diagnostic markers in papillary thyroid carcinoma

2014-11-01 | GSE50901 | GEO

Oncogenic drivers in 11q13 associated with prognosis in advanced oropharyngeal carcinomas

Project description:Oncogenic drivers in 11q13 associated with prognosis in advanced oropharyngeal carcinomas

| PRJNA436909 | ENA

Oncogenic drivers in 11q13 associated with prognosis in advanced oropharyngeal carcinomas (aCGH data set)

Project description:Oncogenic drivers in 11q13 associated with prognosis in advanced oropharyngeal carcinomas (aCGH data set)

| PRJNA436911 | ENA

Oncogenic drivers in 11q13 associated with prognosis in advanced oropharyngeal carcinomas (Expression data set)

Project description:Oncogenic drivers in 11q13 associated with prognosis in advanced oropharyngeal carcinomas (Expression data set)

| PRJNA436910 | ENA

Expression profiling identifies deregulated pathways and top diagnostic markers in papillary thyroid carcinoma

Project description:Expression microarray was used to compare 57 PTC with a reference sample (pool of 9 adjacent normal thyroid tissue) and 4 PTC against 4 matched adjacent normal thyroid tissue. A quality control filter was applied based on Feature Extraction flags (empty spaces replacing values) Experiment condition, 61 PTC and 4 adjacent normal thyroid tissue samples obtained from total thyroidectomies were laleled with Cy3 and a pool of 9 adjacent normal thyroid tissue was labeled with Cy5. Samples Cy3 and Cy5 were mixed and hybridized at slide glasses Agilent 8x60k platform.

2014-11-01 | E-GEOD-50901 | biostudies-arrayexpress

Long-term survival and swallowing outcomes in advanced stage oropharyngeal squamous cell carcinomas.

Project description:BackgroundThere is a paucity of studies reporting long-term survival outcomes for HPV/p16 positive oropharyngeal squamous cell carcinoma (OPSCC). This study aims to compare long-term outcomes of advanced stage p16 positive and negative OPSCCs, treated by surgical and non-surgical modalities.MethodsOPSCC patients from 1998 to 2012 were identified through a prospectively collected cancer registry. P16 immunohistochemistry was used as a surrogate marker for HPV-OPSCC. Overall survival (OS) and aspiration free survival (AFS) comparisons were made between patients treated with chemoradiation (CRT) versus primary surgery and radiation/chemoradiation (S+RT/CRT) at 5, 10 and 15 years post-treatment.ResultsA total of 319 patients were included. P16 positive patients and non-smokers had significantly higher long-term (5, 10 and 15-year) OS. Smokers and p16 negative patients treated with S+RT/CRT had improved long-term OS compared to patients who received CRT. Smokers and p16 negative patients had lower long-term AFS. Multivariate analysis showed improved OS was associated with p16 positivity (HR 0.42, 0.28-0.61) and surgery (HR 0.47, 0.32-0.69), whereas lower OS was associated with ECOG ≥ 2 (HR 2.46, 1.61-3.77), smoking (HR 2.37, 1.41-3.99) and higher stage (HR 1.68, 1.05-2.68).ConclusionsIn smokers and p16-negative OPSCC patients, primary surgery may be associated with improved long-term survival and dysphagia-related outcomes.

| S-EPMC6258135 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data